cells. Increasing evidence indicates that resistin plays an important regulatory role in insulin resistance and in a variety of pathological processes including cardiovascular disease, autoimmune disease, malignancy, asthma, or inflammatory bowel disease. Some proinflammatory markers, such as TNF-α or IL-6 can regulate resistin gene expression. 13 Other evidence linking resistin to inflammation is that plasma resistin levels were found to be associated with numerous inflammatory agents in a number of pathophysiological conditions. According to one study, individuals with clinical signs of severe inflammation showed significantly higher concentrations of resistin compared with healthy individuals.
13,14
The aim of the current study was to identify more sensitive and specific laboratory markers useful in diagnosing inflammatory processes, especially in COPD patients with uncertain prognosis. Therefore, we decided to assess changes in the concentrations of adipocytokines, leptin and resistin, with the hope that they may become new markers useful in the monitoring of COPD.
PATIENTs ANd mEThOds Patients
The study was conducted in 33 patients with COPD, aged from 50 to 87 years (mean, 67 ±11 years), treated in the Department of Allergology and Pulmonary Diseases at the Medical University of Lodz, Łódź, Poland, and later at an outpatient clinic. COPD was confirmed based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) document of 2010. During the previous year, 1 episode of exacerbation was reported in 15 patients and no exacerbations were reported in the remaining 18 patients. Exacerbations in the course of this study were excluded in all patients on the basis of laboratory tests (blood cell count with smear, C-reactive protein [CRP] ) and clinical presentation (absence of dyspnea, normal body temperature, no green sputum expectoration). Lung tumors were excluded by radiological modalities (X-ray, computed tomography). All patients were ex-smokers. In the study group, smoking history was between 25 and 40 years and the mean number of the packs of cigarettes was 25 pack per year.
The control group consisted of 17 age-matched healthy volunteers.
The study protocol was approved by the local ethics committee (approval no. RNN/4/12/KE).
methods The analysis of data obtained from the study groups was conducted using the STATISTICA v. 10 software (StatSoft, Inc., United States). The characteristics were assessed using the t test (parametric variables) or the Mann-Whitney test (nonparametric distribution). Correlations between variables were evaluated by the Pearson correlation test. The results were considered to be statistically significant at a P value of less than 0.05.
Anthropometry
In all patients, body weight and height were measured to calculate the body mass an increase in the CD8 + /CD4 + ratio is observed). During exacerbations, increased counts of eosinophils are also observed in the sputum and airway walls, and in the case of a simultaneous infection -also of B lymphocytes.
4,5
The above inflammatory cells cause direct damage to the pulmonary tissue. Additionally, they produce mediators enhancing the inflammatory response, increasing the migration of inflammatory cells from the bloodstream and causing structural remodeling of the surrounding tissues. The mediators involved in the pathogenesis of COPD include proinflammatory cytokines such as interleukin (IL) 6, tumor necrosis factor-α (TNF-α), and IL-17.
6
The increasing severity of inflammatory processes in the respiratory tract is associated with exacerbation of COPD. This, in turn, is manifested by impairment of the patient's ventilation, which triggers the pathway leading to hypercatabolism, a condition closely associated with the mechanism of cachexia, commonly observed in patients with COPD exacerbations. The pathologic changes involve excessive weight loss with the consequent reduction of the adipose tissue, which is one of the most important endocrine systems in the human body. It is responsible for the synthesis of adipokines, the peptides that play an important role in systemic metabolism. They demonstrate a regulatory effect mainly on lipid metabolism and immune processes.
7,8
One of adipokines, discovered recently but relatively well-known, is leptin, characterized by multidirectional effects both within the central nervous system and in the periphery. Leptin synthesis determines the appropriate expenditure of energy, regulates many basic life processes such as pubescence and reproductive functions. It is also an important factor involved in angiopoiesis, modulation of the production of cytokines by T-helper (Th) lymphocytes, and regulation of the cell cycle. 9, 10 The serum levels of this polypeptide correlate with the systemic adipose tissue mass. The involvement of leptin in the regulation of the hypothalamus-pituitary-adrenal axis and its similarity to the cytokine family may suggest the role of that hormone in acute-phase processes. 11 Recent studies have demonstrated possible immune effects of leptin, exerted by the stimulation of immunocompetent cells. It is particularly significant that the hormone is synthesized by the bone marrow stromal cells and that it stimulates the growth of hematopoietic cells. Leptin can also activate the synthesis of proinflammatory cytokines, such as IL-2, interferon-γ, by Th1 and inhibit the synthesis of cytokines such as IL-4 by Th2. Administration of leptin has been demonstrated to reduce an immunosuppressive effect of this hormone in fasting subjects. 12 Resistin is a newly identified class of cysteine--ich proteins collectively termed resistin-like molecules. Significant expression of resistin in humans is mainly found in mononuclear leukocytes, macrophages, spleen, and bone marrow
Of note, no correlations were observed between leptin levels and the BMI in patients with COPD (r = 0.32; P <0.05). A similar trend was observed for resistin: its mean levels in patients with COPD were twice higher than those in the control group (8.24 ±4.18 ng/ml vs. 3.58 ±1.51 ng/ml, respectively). No correlation between resistin levels and the BMI was noted (r = 0.28; P <0.05). No significant differences in the BMI and WHR between the 2 groups were observed (TAbLE 1) .
Considering the above findings, we decided to investigate the correlation of leptin and resistin with CRP, which is a commonly accepted inflammatory marker. We observed an increase in CRP levels in patients with CRP but it was not statistically significant when compared with the control group (6.47 ±5.03 ng/ml vs. 3.40 ±1.99 ng/ml, respectively; P = 0.064). Significant positive correlations between CRP and leptin as well as CRP and resistin levels were observed in patients with COPD (r = 0.75 and r = 0.83, respectively, P <0.05; FIGuREs 1 and 2). No such correlation was noted in the control group.
We also evaluated correlations between leptin and resistin levels and respiratory function parameters. No correlations were observed between adipokines and oxygen pressure in any of the groups. However, a significant negative correlation between the forced expiratory volume in 1 second (FEV 1 ) and resistin levels was noted in the group of patients with COPD (r = 0.62; P <0.05) (FIGuRE 3) . The values of FEV 1 in the study groups are presented in TAbLE 2. FEV 1 values did not correlate with leptin levels either in patients with COPD or in controls. dIsCussION The aim of our study was to assess whether adipokines, leptin and resistin, can be useful as markers of the inflammatory process in index (BMI), and waist and hip circumference to calculate the waist-to-hip ratio (WHR).
Gasometry Gasometry was performed in the arterial blood. Patients were prepared according to the required standards, and the test was performed using a Corning 348 blood gas analyzer (Ciba Corning, United States).
biochemical investigations Serum CRP levels were measured using a turbidimetric method (OLYMPUS AU 400 biochemical analyzer, Olympus, United States). Leptin and resistin levels were measured by an enzyme-linked immunosorbent assay (Quantikine Human Leptin and Quantikine Human Resistin kits, R&D, United States).
spirometry Spirometry was performed in clinically stable patients without the signs of infection using LUNGTEST 1000 spirometer. If long--acting β-agonists were administered, they were withdrawn 12 hours before the test, while if short-acting β 2 -agonists were administered they were withdrawn 6 hours before the test. Spirometry was performed after a minimum 15-minute rest. Abbreviations: BMI -body mass index, COPD -chronic obstructive pulmonary disease, WHR -waist-to-hip ratio However, it should be emphasized that our study investigated a full-blown inflammatory process as one of only few papers addressing the changes in leptin and resistin levels in COPD.
18,19 Poulain et al. 20 also observed elevated leptin concentrations in patients with COPD; however, in contrast to our results, these changes demonstrated a positive correlation with the BMI. Different results were reported by Yang et al.,
21 who observed significantly lower leptin levels in patients with COPD than in control subjects, especially in the subgroup of patients with cachexia. Of note, our patients showed no signs of cachexia and had similar BMI values to those in controls. This is important because the changes of leptin and resistin levels are dependent on the adipose tissue. As a result, the process of cachexia may be associated with the decreased levels of adipokines.
Similarly to leptin, we obtained different results for resistin compared with the data presented in the literature. In particular, decreased resistin levels were associated with decreased BMI. 20,21 In contrast, Breyer et al. 22 observed no changes in leptin and resistin levels in patients with COPD and the obtained values were comparable to those in the control group. 22 The role of leptin and resistin as inflammatory markers can be confirmed by a positive correlation with CRP, which was also shown in the study of COPD patients by van de Borst et al. 23 In addition, a positive correlation between resistin levels and FEV 1 , which coincides with a positive correlation between resistin levels and CRP, may indicate the association between resistin levels and the severity of COPD.
In conclusion, a significant increase in leptin and resistin levels observed in patients with COPD may suggest that these adipokines are involved in the inflammatory process underlying the disease. COPD. Our results confirmed this hypothesis because the levels of both adipokines were significantly higher and demonstrated a positive correlation with CRP, which is a commonly recognized acute-phase protein. Numerous studies have shown that inflammatory markers are independently associated with circulating leptin and resistin levels in patients with a chronic inflammatory process. 15,16 CRP, a marker of inflammation, was reported to be positively correlated with resistin levels in several pathophysiological conditions.
17 This finding may support the involvement of adipokines in the inflammatory process, which has already been confirmed by a number of studies.
15-17 Moreover, our study confirmed a strong positive correlation between CRP and leptin and CRP and resistin levels. 
